Discover how molecular biomarkers are revolutionizing colorectal cancer treatment by predicting response to radiotherapy and enabling personalized therapies.
Explore the prognostic value of phosphorylated Akt and survivin expression in gastric adenocarcinoma and how these biomarkers predict patient survival.
Discover how RECQL1, a DNA repair enzyme, serves as a powerful prognostic factor in epithelial ovarian cancer and could revolutionize personalized treatment approaches.
Discover how the nuclear localization of survivin protein serves as a positive prognostic factor for survival in advanced non-small-cell lung cancer.